# Septerna Inc. (SEPN)

Source: https://www.quantisnow.com/company/SEPN
Generated: 2026-11-19T15:48:34.502Z

- Ticker: SEPN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2024
- SEC CIK: 0001984086

## Latest SEPN news and filings

- 2026-11-19 00:00 UTC [SEC Form 4] [Chief Financial Officer Gil M Labrucherie sold $832,359 worth of shares (20,000 units at $41.62) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-gil-m-labrucherie-sold-832359-worth-of-6799511)
- 2026-11-17 00:00 UTC [SEC Form 4] [Chief Executive Officer Finer Jeffrey exercised 18,500 shares at a strike of $2.76 and sold $807,015 worth of shares (18,500 units at $43.62) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-finer-jeffrey-exercised-18500-shares-at-a-6795143)
- 2026-11-16 21:45 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6794700)
- 2026-11-14 00:02 UTC [SEC Form 4] [Director Ezekowitz Alan sold $3,934,363 worth of shares (81,820 units at $48.09) as part of a pre-agreed trading plan, decreasing direct ownership by 70% to 35,600 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ezekowitz-alan-sold-3934363-worth-of-shares-81820-units-6791690)
- 2026-11-12 22:59 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6788960)
- 2026-11-12 12:56 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6786381)
- 2026-11-09 21:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-septerna-inc-6781281)
- 2026-11-09 21:04 UTC [SEC Form 8-K] [Septerna Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/septerna-inc-filed-sec-form-8-k-results-of-operations-and-6781117)
- 2026-11-09 21:01 UTC [Earnings] [Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/septerna-highlights-business-progress-and-reports-third-quarter-2026-financial-6781030)
- 2026-11-04 13:15 UTC [SEC Form 8-K] [Septerna Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/septerna-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6771514)
- 2026-11-04 13:00 UTC [Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting](https://www.quantisnow.com/insight/septerna-announces-selection-of-sep-204-as-development-candidate-for-graves-6771420)
- 2026-11-03 13:00 UTC [Conference Announcement] [Septerna to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/septerna-to-participate-in-upcoming-investor-conferences-6768449)
- 2026-10-19 23:00 UTC [SEC Form 4] [President and COO Bhatt Elizabeth sold $149,644 worth of shares (4,000 units at $37.41) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-and-coo-bhatt-elizabeth-sold-149644-worth-of-shares-6751100)
- 2026-09-10 21:08 UTC [SEC Form 4] [SEC Form 4 filed by Chief Medical Officer Patni Rajiv](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-medical-officer-patni-rajiv-6712024)
- 2026-09-10 20:00 UTC [Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/septerna-inc-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-6711464)
- 2026-09-03 23:03 UTC [SEC Form 3] [SEC Form 3 filed by new insider Patni Rajiv](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-patni-rajiv-6705912)
- 2026-09-03 23:01 UTC [SEC Form 4] [SVP, Drug Discovery Long Daniel D. exercised 3,333 shares at a strike of $2.76 and sold $126,078 worth of shares (3,333 units at $37.83) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/svp-drug-discovery-long-daniel-d-exercised-3333-shares-at-6705910)
- 2026-09-01 12:00 UTC [Conference Announcement] [Septerna to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/septerna-to-participate-in-upcoming-investor-conferences-6700575)
- 2026-08-25 12:15 UTC [SEC Form 8-K] [Septerna Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/septerna-inc-filed-sec-form-8-k-regulation-fd-disclosure-6693667)
- 2026-08-25 12:00 UTC [Leadership Update] [Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer](https://www.quantisnow.com/insight/septerna-appoints-industry-veteran-rajiv-patni-md-as-chief-medical-6693610)
- 2026-08-14 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Third Rock Ventures V, L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-third-rock-ventures-6683814)
- 2026-08-14 21:14 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Septerna Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-septerna-inc-6683669)
- 2026-08-14 21:11 UTC [SEC Form 4] [Director Ra Capital Management, L.P. sold $63,452,500 worth of shares (1,493,000 units at $42.50) (SEC Form 4)](https://www.quantisnow.com/insight/director-ra-capital-management-lp-sold-63452500-worth-of-shares-6683651)
- 2026-08-14 11:32 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Septerna Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-septerna-inc-6681823)
- 2026-08-13 23:00 UTC [SEC Form 4] [President and COO Bhatt Elizabeth exercised 25,000 shares at a strike of $5.79 and sold $1,100,000 worth of shares (25,000 units at $44.00) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-and-coo-bhatt-elizabeth-exercised-25000-shares-at-a-6681498)
- 2026-08-12 23:06 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6678820)
- 2026-08-12 22:55 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6678801)
- 2026-08-12 20:09 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6677899)
- 2026-08-11 20:28 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6676110)
- 2026-08-10 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-septerna-inc-6673642)
- 2026-08-10 20:03 UTC [SEC Form 8-K] [Septerna Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/septerna-inc-filed-sec-form-8-k-results-of-operations-and-6673488)
- 2026-08-10 20:01 UTC [Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/septerna-highlights-business-progress-and-reports-second-quarter-2026-financial-6673435)
- 2026-08-05 23:00 UTC [SEC Form 4] [SVP, Drug Discovery Long Daniel D. sold $114,920 worth of shares (3,334 units at $34.47) as part of a pre-agreed trading plan and exercised 3,334 shares at a strike of $2.76 (SEC Form 4)](https://www.quantisnow.com/insight/svp-drug-discovery-long-daniel-d-sold-114920-worth-of-6666613)
- 2026-07-17 23:00 UTC [SEC Form 4] [President and COO Bhatt Elizabeth sold $135,974 worth of shares (4,000 units at $33.99) as part of a pre-agreed trading plan and exercised 4,000 shares at a strike of $6.81 (SEC Form 4)](https://www.quantisnow.com/insight/president-and-coo-bhatt-elizabeth-sold-135974-worth-of-shares-6641583)
- 2026-07-15 20:23 UTC [SEC Form 144] [SEC Form 144 filed by Septerna Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-septerna-inc-6638382)
- 2026-07-02 23:00 UTC [SEC Form 4] [SVP, Drug Discovery Long Daniel D. exercised 3,333 shares at a strike of $2.76 and sold $114,528 worth of shares (3,333 units at $34.36) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/svp-drug-discovery-long-daniel-d-exercised-3333-shares-at-6626788)
- 2026-06-30 23:52 UTC [SEC Form 4] [SEC Form 4 filed by Director Ra Capital Management, L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ra-capital-management-lp-6621472)
- 2026-06-30 23:01 UTC [SEC Form 4] [Chief People Officer Shaikhly Samira exercised 2,178 shares at a strike of $6.81 and sold $76,622 worth of shares (2,178 units at $35.18) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-people-officer-shaikhly-samira-exercised-2178-shares-at-a-6621441)
- 2026-06-30 23:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Bassan Abraham](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bassan-abraham-6621437)
- 2026-06-30 23:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Tong Jeffrey K](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-tong-jeffrey-k-6621436)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SEPN
- Earnings history: https://www.quantisnow.com/earnings/SEPN
- Dividend history: https://www.quantisnow.com/dividends/SEPN
- Insider transactions: https://www.quantisnow.com/insiders/SEPN
- Options chain: https://www.quantisnow.com/options/SEPN
- SEC 8-K filings only: https://www.quantisnow.com/company/SEPN/8-k
- RSS and alerts for SEPN: https://www.quantisnow.com/docs/rss-feeds.md
